Context-dependent associations between variation in risk of ischemic heart disease and variation in the 5ε promoter region of the Apolipoprotein E gene in Danish women

Circulation: Cardiovascular Genetics

Volumn 3, Issue 1, 2010, Pages 22-30

  Stengård, Jari H ^a   Dyson, Greg ^a   Frikke Schmidt, Ruth ^b   Tybjærg Hansen, Anne ^b,c   Nordestgaard, Borge G ^c,d   Sing, Charles F ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Mental Health Services CPH   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Atherosclerosis; Genetics; Risk factors

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; TRIACYLGLYCEROL;

ADULT; AGED; ALLELE; APOLIPOPROTEIN E GENE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DENMARK; EXON; FEMALE; FOLLOW UP; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; AGE; ALGORITHM; BLOOD; GENETIC PREDISPOSITION; GENETICS; HEART MUSCLE ISCHEMIA; HYPERTENSION; MIDDLE AGED; PREDICTION AND FORECASTING; RISK FACTOR;

AGE FACTORS; AGED; ALGORITHMS; ALLELES; APOLIPOPROTEINS E; DENMARK; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; PROMOTER REGIONS, GENETIC; RISK FACTORS; TRIGLYCERIDES;

EID: 77952468043     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.109.862748     Document Type: Article

References (52)

1. Steinberg D. An interpretive history of the cholesterol controversy: part 1. J Lipid Res. 2004;45:1583-1593.
2. Crawford DC, Akey DT, Nickerson DA. The patterns of natural variation in human genes. Annu Rev Genomics Hum Genet. 2005;6:287-312.
3. Department of Genome Sciences, University of Washington, Nickerson Group. Welcome to MDECODE. Available at: http://droog.gs.washington.edu/ mdecode.
4. Fullerton SM, Clark AG, Weiss KM, Nickerson DA, Taylor SL, Stengård JH, Salomaa V, Vartiainen E, Perola M, Boerwinkle E, Sing CF. Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet. 2000;67:881-900.
5. Nickerson DA, Taylor SL, Fullerton SM, Weiss KM, Clark AG, Stengård JH, Salomaa V, Boerwinkle E, Sing CF. Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene. Genome Res. 2000;10:1532-1545.
6. Fullerton SM, Buchanan AV, Sonpar VA, Taylor SL, Smith JD, Carlson CS, Salomaa V, Stengård JH, Boerwinkle E, Clark AG, Nickerson DA, Weiss KM. The effects of scale: variation in the APOA1/C3/A4/A5 gene cluster. Hum Genet. 2004;115:36-56.
7. Hegele RA, Dichgans M. Update on the genetics of stroke and cerebrovascular disease 2007. Stroke. 2008;39:252-254.
8. Sing CF, Stengård JH, Kardia SL. Genes, environment, and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2003;23:1190 -1196.
9. Ioannidis JPA Prediction of Cardiovascular Disease Outcomes and Established Cardiovascular risk Factors by Genome-Wide Association Markers. Circ Cardiovasc Genet. 2009;2:7-15.
10. Guttmacher AE, Collins FS. Realizing the promise of genomics in biomedical research. J Am Med Assoc. 2005;294:1399-1402.
11. van Asselt KM, Kok HS, van der Schouw YT, Peeters PH, Pearson PL, Grobbee DE. Role of genetic analyses in cardiology: part II: heritability estimation for gene searching in multifactorial diseases. Circulation. 2006;113:1136-1139.
12. Humphries SE, Yiannakouris N, Talmud PJ. Cardiovascular disease risk prediction using genetic information (gene scores): is it really informative? Curr Opin Lipidol. 2008;19:128-132.
13. Sing CF, Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet. 1985;37:268-285.
14. Wilson PWF, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease: the Framingham Offspring Study. J Am Med Assoc. 1994;272: 1666-1671.
15. Davignon J, Cohn JS, Mabile L, Bernier L. Apolipoprotein E and atherosclerosis: insight from animal and human studies. Clin Chim Acta. 1999;286:115-143.
16. Stengård JH, Kardia SL, Hamon SC, Frikke-Schmidt R, Tybjærg-Hansen A, Salomaa V, Boerwinkle E, Sing CF. Contribution of regulatory and structural variations in APOE to predicting dyslipidemia. J Lipid Res. 2006;47:318-328.
17. Hegele RA. Plasma lipoproteins: genetic influences and clinical implications. Nat Rev Genet. 2009;10:109-121.
18. Wilson PWF, Schaefer EJ, Larson MG, Ordovas JM. Apolipoprotein E alleles and risk of coronary disease: a meta-analysis. Arterioscler Thromb Vasc Biol. 1996;16:1250-1255.
19. Stengård JH, Frikke-Schmidt R, Tybjærg-Hansen A, Nordestgaard BG, Sing CF. Variation in 5' promoter region of the APOE gene contributes to predicting ischemic heart disease (IHD) in the population at large: the Copenhagen City Heart Study. Ann Hum Genet. 2007;71:762-771.
20. Dyson G, Frikke-Schmidt R, Nordestgaard BG, Tybjærg-Hansen A, Sing CF. An application of the Patient Rule-Induction Method for evaluating the contribution of the apolipoprotein E and lipoprotein lipase genes to predicting ischemic heart disease. Genet Epidemiol. 2007;31:515-527.
21. Dyson G, Frikke-Schmidt R, Nordestgaard BG, Tybjærg-Hansen A, Sing CF. Modifications to the Patient Rule-Induction Method that utilize nonadditive combinations of genetic and environmental effects to define partitions that predict ischemic heart disease. Genet Epidemiol. 2009;33: 317-324.
22. Frikke-Schmidt R, Nordestgaard BG, Agerlholm-Larsen B, Schnohr P, Tybjærg-Hansen A. Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype. J Lipid Res. 2000;41:1812-1822.
23. Frikke-Schmidt R, Sing CF, Nordestgaard BG, Tybjærg-Hansen A. Gender- and age-specific contributions of additional DNA sequence variation in the 5' regulatory region of the APOE gene to prediction of measures of lipid metabolism. Hum Genet. 2004;115:331-345.
24. Schnohr P, Jensen G, Lange P, Scharling H, Appleyard M. The Copenhagen City Heart Study. Eur Heart J Suppl. 2001;3:H1-H83.
25. Frikke-Schmidt R, Sing CF, Nordestgaard BG, Steffensen R, Tybjærg- Hansen A. Subsets of SNPs define rare genotype classes that predict ischemic heart disease. Hum Genet. 2007;120:865-877.
26. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res. 1990;31: 545-548.
27. Friedman JH, Fisher NI. Bump hunting in high-dimensional data. Stat Comput. 1999;9:123-143.
28. Gordon T, Kannel WB. Multiple risk functions for predicting coronary heart disease: the concept, accuracy, and application. Am Heart J. 1982; 103:1031-1039.
29. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847.
30. Arnett DK, Baird AE, Barkley RA, Basson CT, Boerwinkle E, Ganesh SK, Herrington DM, Hong YL, Jaquish C, McDermott DA, O'Donnell CJ. Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the StrokeCouncil, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation. 2007;115:2878-2901.
31. Kannel WB, D'Agostino RB, Sullivan L, Wilson PW. Concept and usefulness of cardiovascular risk profiles. Am Heart J. 2004;148:16-26.
32. Steinberg D. The statins in preventive cardiology. N Engl J Med. 2008; 359:1426-1427.
33. McGill HC Jr. Atherosclerosis: problems in endpoints for genetic analysis. Prog Clin Biol Res. 1979;32:27-49.
34. Zethelius B, Berglund L, Sundström J, Ingelsson E, Basu S, Larsson A, Venge P, Arnlöv J. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med. 2008;358:2107-2116.
35. Johnson KM, Dowe DA, Brink JA. Traditional clinical risk assessment tools do not accurately predict coronary atherosclerotic plaque burden: a CT angiography study. Am J Roentgenol. 2009;192:235-243.
36. Barrett-Connor E, Giardina EG, Gitt AK, Gudat U, Steinberg HO, Tschoepe D. Women and heart disease: the role of diabetes and hyperglycemia. Arch Intern Med. 2004;164:934-942. (Pubitemid 38581511)
37. Barrett-Connor E. Women and cardiovascular disease. Can Med Assoc J. 2007;176:791-793.
38. Kim ESH, Menon V. Status of women in cardiovascular clinical trials. Arteroscler Thromb Vasc Biol. 2009;29:279-283.
39. Lambert JC, Coyle N, Lendon C. The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer's disease. J Med Genet. 2004;41:104-112.
40. Weiss KM. Tilting at quixotic trait loci (QTL): an evolutionary perspective on genetic causation. Genetics. 2008;179:1741-1756.
41. Noble D. The Music of Life: Biology Beyond the Genome. New York, NY: Oxford University Press; 2006.
42. Lewontin RC. The analysis of variance and the analysis of causes. Int J Epidemiol. 2006;35:520-525.
43. Lewontin RC. The Triple Helix: Gene, Organism, and Environment. Cambridge, MA: Harvard University Press; 2002.
44. Kaprio J, Ferrell RE, Kottke BA, Kamboh MI, Sing CF. Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease. Arterioscler Thromb. 1991;11: 1330-1348.
45. Nelson LM, Bloch DA, Longstreth WT Jr, Shi H. Recursive partitioning for the identification of disease risk subgroups: a case-control study of subarachnoid hemorrhage. J Clin Epidemiol. 1998;51:199-209.
46. Stengård JH, Kardia SL, Tervahauta M, Ehnholm C, Nissinen A, Sing CF. Utility of the predictors of coronary heart disease mortality in a longitudinal study of elderly Finnish men aged 65 to 84 years is dependent on context defined by ApoE genotype and area of residence. Clin Genet. 1999;56:367-377.
47. Stengård JH, Salomaa V, Rasi V, Vahtera E, Ehnholm C, Krusius T, Perola M, Vartiainen E. Utility of the Arg/Gin polymorphism of the factor VII (FVII) gene, serum lipid levels and body mass index in the prediction of the FVII:C and FVII:Ag in North Karelia: a cross-sectional and prospective study. Blood Coagul Fibrinolysis. 2001;12:445-452.
48. Koss N, Feinstein AR. Computer-aided prognosis. II. Development of a prognostic algorithm. Arch Intern Med. 1971;127:448-459.
49. Marshall RJ. The use of classification and regression trees in clinical epidemiology. J Clin Epidemiol. 2001;54:603-609.
50. Fletcher RW, Fletcher SW. Clinical Epidemiology: The Essentials. 4th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2005.
51. Kraft P, Wacholder S, Cornelis MC, Hu FB, Hayes RB, Thomas G, Hoover R, Hunter DJ, Chanock S. Beyond odds ratios- communicating disease risk based on genetic profiles. Nat Rev Genet. 2009;10:264-269.
52. Conway PH, Clancy C. Comparative-effectiveness research- implications of the Federal Coordinating Council's Report. N Engl J Med. 2009;361:328-330.